Y Brychtová Selected Research

Y Brychtová Research Topics

3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2014 - 01/2006
2	Thrombocytopenia (Thrombopenia) 07/2008 - 09/2001
1	Residual Neoplasm 04/2014
1	Hemorrhage 02/2011
1	Leukemia 02/2011
1	Portal Hypertension 02/2011
1	Splenomegaly 02/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 06/2009
1	Trisomy (Trisomies) 06/2009
1	Drug-Related Side Effects and Adverse Reactions 07/2008
1	Thrombocytosis (Thrombocythemia) 05/2006
1	Essential Thrombocythemia 05/2006
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 05/2006
1	Neoplasms (Cancer) 01/2006
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2005
1	Infections 03/2002
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2002
1	Pain (Aches) 09/2001
1	Lymphocytosis 05/2000
1	Hypertension (High Blood Pressure) 03/2000
1	Essential Hypertension 03/2000

2	Pharmaceutical PreparationsIBA 05/2006 - 03/2002
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2011
1	Hemoglobins (Hemoglobin)IBA 02/2011
1	Alemtuzumab (Campath)FDA Link 06/2009
1	anagrelide (Agrylin)FDA LinkGeneric 05/2006
1	Rituximab (Mabthera)FDA Link 01/2006
1	AntigensIBA 01/2006
1	NucleotidesIBA 01/2006
1	CD20 AntigensIBA 01/2006
1	Immunoglobulins (Immunoglobulin)IBA 01/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2005
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2001
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2000
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2000